Antioxidant Sestrin-2 Redistribution to Neuronal Soma in Human Immunodeficiency Virus-Associated Neurocognitive Disorders

[1]  A. Budanov.  Stress-responsive sestrins link p53 with redox regulation and mammalian target of rapamycin signaling. , 2011, Antioxidants & redox signaling.

[2]  Anil Kumar,et al.  Methamphetamine toxicity and its implications during HIV-1 infection , 2011, Journal of NeuroVirology.

[3]  W. Banks,et al.  Highly active antiretroviral therapy drug combination induces oxidative stress and mitochondrial dysfunction in immortalized human blood-brain barrier endothelial cells. , 2011, Free radical biology & medicine.

[4]  Terry L. Jernigan,et al.  HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors , 2010, Journal of NeuroVirology.

[5]  Hyoung-Gon Lee,et al.  Antioxidant approaches for the treatment of Alzheimer’s disease , 2010, Expert Review of Neurotherapeutics.

[6]  D. Jeste,et al.  Short-term recognition memory impairment is associated with decreased expression of FK506 binding protein 51 in the aged mouse brain , 2010, AGE.

[7]  Mark H. Ellisman,et al.  Sestrin as a Feedback Inhibitor of TOR That Prevents Age-Related Pathologies , 2010, Science.

[8]  H. Vinters,et al.  Cerebral Microinfarcts Associated with Severe Cerebral β‐Amyloid Angiopathy , 2010, Brain pathology.

[9]  M. Sofroniew,et al.  Astrocytes: biology and pathology , 2009, Acta Neuropathologica.

[10]  I. Ferrer,et al.  Human brain cortex: mitochondrial oxidative damage and adaptive response in Parkinson disease and in dementia with Lewy bodies. , 2009, Free radical biology & medicine.

[11]  W. Banks,et al.  N-Acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells , 2009, Brain Research.

[12]  K. Khalili,et al.  Activation of the Oxidative Stress Pathway by HIV-1 Vpr Leads to Induction of Hypoxia-inducible Factor 1α Expression* , 2009, Journal of Biological Chemistry.

[13]  S. Jayadev,et al.  Host and Viral Factors Influencing the Pathogenesis of HIV-Associated Neurocognitive Disorders , 2009, Journal of Neuroimmune Pharmacology.

[14]  C. Farthing,et al.  An exploratory study of long-term neurocognitive outcomes following recovery from opportunistic brain infections in HIV+ adults , 2008, Journal of clinical and experimental neuropsychology.

[15]  J. McArthur,et al.  Nitrosative stress with HIV dementia causes decreased L-prostaglandin D synthase activity , 2008, Neurology.

[16]  P. Ghazal,et al.  Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses , 2008, Nature Neuroscience.

[17]  Andrew King,et al.  Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium , 2008, Brain pathology.

[18]  A. Venkatesan,et al.  Evolution of HIV dementia with HIV infection , 2008, International review of psychiatry.

[19]  W. Markesbery,et al.  Oxidative damage in mild cognitive impairment and early Alzheimer's disease , 2007, Journal of neuroscience research.

[20]  J. Becker,et al.  Updated research nosology for HIV-associated neurocognitive disorders , 2007, Neurology.

[21]  M. Mattson,et al.  Associative and predictive biomarkers of dementia in HIV-1–infected patients , 2007, Neurology.

[22]  D. Butterfield,et al.  Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI)—2′,3′-dideoxycytidine (ddC): Relevance to HIV-dementia , 2007, Experimental Neurology.

[23]  Caroline Anderson,et al.  Oxidative stress and therapeutic approaches in HIV dementia. , 2006, Antioxidants & redox signaling.

[24]  Xiongwei Zhu,et al.  Involvement of Oxidative Stress in Alzheimer Disease , 2006, Journal of neuropathology and experimental neurology.

[25]  A. Nath,et al.  Estrogen attenuates gp120‐ and tat1–72‐induced oxidative stress and prevents loss of dopamine transporter function , 2006, Synapse.

[26]  P. Chumakov,et al.  The antioxidant function of the p53 tumor suppressor , 2005, Nature Medicine.

[27]  Michael J. Taylor,et al.  Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors , 2005, Journal of NeuroVirology.

[28]  L. Hersh,et al.  Tat and amyloid: multiple interactions. , 2005, AIDS.

[29]  V. Valcour,et al.  HIV-associated dementia, mitochondrial dysfunction, and oxidative stress. , 2004, Mitochondrion.

[30]  E. Koonin,et al.  Regeneration of Peroxiredoxins by p53-Regulated Sestrins, Homologs of Bacterial AhpD , 2004, Science.

[31]  M. Mattson,et al.  Perturbation of sphingolipid metabolism and ceramide production in HIV‐dementia , 2004, Annals of neurology.

[32]  D. Butterfield,et al.  Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants , 2003, Neurology.

[33]  A. Chajut,et al.  Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability , 2002, Oncogene.

[34]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[35]  A. Nunomura,et al.  Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[36]  A. Bansal,et al.  Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum , 2001, Neuroscience Letters.

[37]  M. Mattson,et al.  HIV-1 Protein Tat Induces Apoptosis of Hippocampal Neurons by a Mechanism Involving Caspase Activation, Calcium Overload, and Oxidative Stress , 1998, Experimental Neurology.

[38]  C P Das,et al.  Neurological complications of HIV infection. , 1998, Neurology India.

[39]  J. Endicott,et al.  Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. , 1996, The American journal of psychiatry.

[40]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology Confirmation of the Clinical Diagnosis of Alzheimer's Disease , 1995, Neurology.

[41]  D. Price,et al.  Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. , 1995, The American journal of pathology.

[42]  N. Robakis,et al.  Immunohistochemical evidence of antioxidant stress in Alzheimer's disease , 1992 .

[43]  A. Farmer,et al.  The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. , 1988, Archives of general psychiatry.

[44]  George Perry,et al.  Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. , 2010, Journal of Alzheimer's disease : JAD.

[45]  Michael Karin,et al.  p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling , 2009, Cell.

[46]  N. Robakis,et al.  Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease. , 1992, The American journal of pathology.